Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M.
Hirata Y, et al. Among authors: nakaya y.
Eur J Pharmacol. 2013 Jan 15;699(1-3):106-11. doi: 10.1016/j.ejphar.2012.11.057. Epub 2012 Dec 7.
Eur J Pharmacol. 2013.
PMID: 23220706